News

2019

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Evelo Biosciences Appoints Juan Andres to Board of Directors

Evelo Biosciences 12.05.2019

Evelo Biosciences Announces the Appointment of David Epstein as Chairman of its Board of Directors

Evelo Biosciences 09.17.2019

Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial

Evelo Biosciences 08.06.2019

Evelo Biosciences Secures $45 Million Debt Financing from K2 HealthVentures

Evelo Biosciences 07.25.2019

Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma

Evelo Biosciences 01.28.2019

Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications

Evelo Biosciences 01.04.2019

Loading